The new HF-index enables accurate, on-demand heart failure severity tracking using single-lead ECG data from wearable devices....
First-of-Its-Kind, FDA-Approved, Needle-Free, Portable Radio Frequency Device Now Available in the U.S. Market ...
Innovative endovascular treatment for communicating hydrocephalus gains regulatory support for patients aged 12 and older....
FINDER® platform enables rapid, low-volume Anti-Factor Xa testing, transforming anticoagulation care at the bedside....
The regulatory milestone paves the way for broader adoption of its neuroimaging solutions across North America....
Single-use, 2-channel wearable Biosensor, patient-facing app and cloud-based system enable final Holter reports in hours—not days. ...
The policy expands access to this effective, non-drug treatment for members as young as 8 years old who are diagnosed with migraine ...
The FDA has granted authorisation for Minder under its De Novo pathway creating a new classification of device, allowing for marketing and sale of the device in the US for patients with drug resistant epilepsy...
New system features higher viscoelastic capacity and TruSync™ technology, engineered to safely synchronize surgical control and precision in implant-free, comprehensive MIGS ...
New system enhances real-time patient assessment, enabling clinicians to make faster, data-driven decisions. ...
